Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Pharmacology & Therapeutics|July 26, 2005
Involving the pharmaceutical and biotech communities in medication development for substance abuseCharles W Gorodetzky, Charles GrudzinskasNicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 11, 2003
Efficacy of over-the-counter nicotine patchSaul Shiffman, Jane Gorsline, Charles W GorodetzkyJournal of Addiction Medicine|December 12, 2018
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical TrialMarc Fishman, Carlos Tirado, Danesh Alam, et al.Addictive Behaviors|April 29, 2016
Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxificationMargaret K Vernon, Stefan Reinders, Sally Mannix, et al.Drug and Alcohol Dependence|May 21, 2017
A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawalCharles W Gorodetzky, Sharon L Walsh, Peter R Martin, et al.Addiction (Abingdon, England)|May 30, 2002
Real-world efficacy of prescription and over-the-counter nicotine replacement therapySaul Shiffman, Clyde N Rolf, Stephen J Hellebusch, et al.Drug and Alcohol Dependence|April 4, 2006
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel reportCharles Grudzinskas, Robert L Balster, Charles W Gorodetzky, et al.Drug and Alcohol Dependence|September 29, 2009
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel reportChris-Ellyn Johanson, Robert L Balster, Jack E Henningfield, et al.JAMA Psychiatry|April 12, 2013
A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependenceEugene C Somoza, Douglas Winship, Charles W Gorodetzky, et al.International Clinical Psychopharmacology|February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressantsClotilde Guidetti, George I Papakostas, Steven Stahl, et al.Pageof 2